Rick Bienkowski
Stock Analyst at Cantor Fitzgerald
(0)
# 4971
Out of 5,298 analysts
36
Total ratings
16.67%
Success rate
-34.78%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BEAM Beam Therapeutics | Reiterates: Overweight | n/a | n/a | n/a | 12 | Mar 12, 2025 | |
LEGN Legend Biotech | Reiterates: Overweight | 83 83 | 32.96 | 151.82% | 2 | Dec 9, 2024 | |
ACLX Arcellx | Initiates Coverage On: Overweight | n/a | n/a | n/a | 1 | Sep 3, 2024 | |
NTLA Intellia Therapeutic... | Reiterates: Overweight | 65 65 | 6.88 | 844.77% | 7 | Jun 24, 2024 | |
CRBU Caribou Biosciences | Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 22 | 3.85 | 471.43% | 3 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 14 | 1.12 | 1150% | 6 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 112 107 | 32.67 | 227.52% | 4 | Aug 8, 2022 |